Clinical trial
Antithymocyte Globulin in Treating Patients Undergoing Stem Cell Transplant for…
NCT00378768 · Fred Hutchinson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00378768 |
|---|---|
| Title | Antithymocyte Globulin in Treating Patients Undergoing Stem Cell Transplant for Multiple Myeloma |
| Official title | A Phase II Study of Thymoglobulin in Patients With Multiple Myeloma Who Are Candidates for Allogeneic or Autologous Stem Cell Transplant |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma and Plasma Cell Neoplasm |
| Intervention type | Biological |
| Interventions | anti-thymocyte globulin |
| Enrollment | 12 |
| Start date | Nov 1, 2005 |
| Completion | Jun 1, 2007 |
| First posted | Sep 21, 2006 |
| Last update posted | Nov 30, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: